2 Patents
- US125443782026Solid Pharmaceutical Formulation of PARP Inhibitors and Use Thereof
Impact Therapeutics (Shanghai), Inc
0 cites - US115477032023Substituted Fused Heteroaromatic Tricyclic Compounds as Kinase Inhibitors and the Use Thereof
IMPACT THERAPEUTICS (SHANGHAI), Inc
0 cites